Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada.
Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada; Cité-de-la-Santé Hospital, Laval, Québec, Canada.
Cardiovasc Revasc Med. 2021 Sep;30:33-37. doi: 10.1016/j.carrev.2020.09.024. Epub 2020 Sep 19.
Coronavirus disease 2019 (COVID-19) has forced dramatic changes to the healthcare systems throughout the world. Time-sensitive management of cardiovascular emergencies such as ST-elevation myocardial infarction (STEMI) has yet to be evaluated in the context of these new policies, particularly in so-called "hot spot" cities.
We evaluated the early impact of the pandemic on STEMI performance in the Greater Montreal Area. A total of 167 patients from 3 different study periods were included. Patients presenting in the lockdown period from mid-March to mid-May 2020 (Group C, 53 patients) were compared to those from mid-March to mid-May 2019 (Group A, 60 patients) and the 2020 pre-COVID-19 period (Group B, 54 patients).
The number of STEMI admissions was unaffected during the lockdown. However, significantly longer delays between symptom onset and first medical contact (FMC) were noted (Group C 189.0 IQR [70.0, 840.0] min vs. Group A 103.0 IQR [42.5, 263.0] min vs. Group B 91.0 IQR [38.0, 235.5 min], P = 0.007). In contrast, additional safety protocols do not appear to have significantly affected delays between FMC and first intracoronary device activation (Group C 102 IQR [73.0, 133.0] min vs. Group A 104 IQR [87.0, 146.0] min vs. Group B 99.5 IQR [80.0, 150.0] min, P = 0.37). Patients that presented during the outbreak were more likely to be unstable with a higher incidence of Killip classes II-IV compared to groups A and B (28.3% vs. 18.3% vs. 5.6% respectively, P = 0.008). Worse in-hospital outcomes were also noted with a significantly higher rate of major adverse cardiac events (Group A 5.0% vs. Group B 11.1% vs. Group C 22.6%, P = 0.007).
During the lockdown period, many patients appear to have been reluctant to present to hospitals. This was associated with more unstable STEMI presentations and worse in-hospital course. Importantly, the health care system appears able to ensure timely acute cardiac care while ensuring that COVID-19 protocols are respected.
2019 年冠状病毒病(COVID-19)迫使全球医疗系统发生了重大变化。心血管急症的时间敏感管理,如 ST 段抬高型心肌梗死(STEMI),尚未在这些新政策背景下进行评估,特别是在所谓的“热点”城市。
我们评估了大蒙特利尔地区大流行对 STEMI 表现的早期影响。总共纳入了来自 3 个不同研究期的 167 名患者。与 2019 年 3 月至 5 月中旬(组 A,60 名患者)和 2020 年 COVID-19 前(组 B,54 名患者)相比,在 2020 年 3 月至 5 月中旬的封锁期间就诊的患者(组 C,53 名患者)。
封锁期间 STEMI 入院人数没有增加。然而,首次医疗接触(FMC)前的时间明显延长(组 C 189.0 IQR [70.0, 840.0] min vs. 组 A 103.0 IQR [42.5, 263.0] min vs. 组 B 91.0 IQR [38.0, 235.5 min],P=0.007)。相比之下,额外的安全协议似乎并没有显著影响 FMC 和首次经皮冠状动脉介入治疗设备激活之间的时间延迟(组 C 102 IQR [73.0, 133.0] min vs. 组 A 104 IQR [87.0, 146.0] min vs. 组 B 99.5 IQR [80.0, 150.0] min,P=0.37)。与组 A 和 B 相比,在疫情期间就诊的患者更不稳定,Killip 分级 II-IV 的发生率更高(分别为 28.3%、18.3%和 5.6%,P=0.008)。住院期间也出现了更差的结果,主要不良心脏事件的发生率显著更高(组 A 5.0%,组 B 11.1%,组 C 22.6%,P=0.007)。
在封锁期间,许多患者似乎不愿意去医院就诊。这与更不稳定的 STEMI 表现和更差的住院病程有关。重要的是,医疗保健系统似乎能够确保及时进行急性心脏护理,同时确保遵守 COVID-19 协议。